The U.S. Food and Drug Administration (FDA) has cited the Hennepin County Medical Center in Minnesota over its institutional review board’s (IRB) oversight of clinical trials including one case involving dosing emergency patients with ketamine without the patients’ consent. Public Citizen called on the FDA to suspend the hospital’s IRB until they took corrective steps to ensure adequate protections for research subjects going forward. (Regulatory Focus)